The lunch and lecture provided scientific updates on sustained acoustic medicine research in sports medicine, significant product innovations, and the new 2023 Player Performance Package (PPP).

SAN DIEGO - January 5, 2023 - (Newswire.com)

ZetrOZ Systems hosted a Lunch and Lecture for The Professional Baseball Athletic Trainers Society (PBATS) during the Major League Baseball Winter Meetings at the Manchester Grand Hyatt in San Diego, California. Founder and CEO Dr. George Lewis presented scientific updates on sustained acoustic medicine (sam®) research in sports medicine, reviewed a 2022 Healthcare Provider Survey on utilization within professional athletics and results from real-world clinicals, and introduced its Player Performance Packages for 2023.

"It was a pleasure to have the opportunity to speak with The Professional Baseball Athletic Trainers Society," said Dr. Lewis. "I am grateful for the opportunity to share my knowledge and recent findings with such a professional and dedicated group of trainers. I look forward to continuing the conversation and working together to improve the health, performance and recovery of athletes in the future."

Some of the key findings from the latest sports medicine research include the following:

• Professional sports medical staff had an 87% satisfaction rate p<0.001 and increased confidence in sam® to accelerate the healing process from injuries related to overuse (Draper et al. 2021 J. Ortho. Practice).
• When patients failed to respond to physical therapy, sam® proved to be a helpful adjunct to facilitate healing and return to work (Winkler et al. 2021 Nature Sports Med).
• Athletic Trainers working within the professional, collegiate and military levels found sam® provided clinical patient improvement in under two weeks of treatment and a 50% reduction of pain medication p<0.001 (Walters et al. 2022 Open Orthopedics).
• 87.3% of athletes are highly receptive to treatment, have a high confidence level for improved function, and return to work after 30 days of sam® use p<0.001 (Walters et al. 2022, Open Orthopedics).

Over 30 studies back sustained acoustic medicine's effectiveness, and over 1 million individuals have used sam® to treat soft tissue injuries. Today, 99% of Major League Baseball (MLB) organizations utilize sam® to treat injuries and accelerate soft tissue healing.

Dr. Lewis also introduced the company's 2023 Player Performance Packages, designed for prophylactic injury prevention and soft tissue healing. A package includes one sam®x1 unit, a 10-week supply of patches, and 100% damage coverage. ZetrOZ is preparing its deployment training over the next several weeks before MLB's 2023 Spring Training, officially beginning on Friday, Feb. 24.

"Now every player from the big leagues to the minors has access to sam® treatment. We are looking to reduce common injuries to the shoulder and elbow," he added.

sam® is the first and only FDA-cleared, non-surgical and drug-free wearable long-duration mechanobiological device for home use designed to treat chronic inflammatory diseases and accelerate soft tissue healing. To learn more, visit zetroz.com.

About ZetrOZ Systems

ZetrOZ Systems is leading healing innovations in sports medicine and developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on proprietary medical technology of +46 patents and is the exclusive manufacturer and developer of sam®, a product line designed for the treatment of acute and chronic musculoskeletal conditions. To learn more, visit zetrozsystems.com.

Contact Information:
Buse Kayar
[email protected]


Press Release Service by Newswire.com

Original Source: ZetrOZ Systems Hosts Lunch and Lecture for the Professional Baseball Athletic Trainers Society

Potrero Medical CEO, Joe Urban, Invited to Present Wednesday Jan 11 @ 10:30 a.m. PST

HAYWARD, Calif. - January 5, 2023 - (Newswire.com)

Potrero Medical, innovator of the Accuryn Monitoring System, announced today that it accepted an invitation to present at the 41^st Annual J.P. Morgan Healthcare Conference in San Francisco Jan. 9-12, 2023.  Joe Urban, Potrero's Chief Executive Officer, has been invited to  present on Wednesday, Jan. 11, at 10:30 a.m. PT in the Golden Gate conference room of the Westin St. Francis Hotel.

Urban commented, "It is exciting that the JP Morgan Healthcare Conference will be in person this year. We are honored to be invited to present. I am looking forward to the opportunity to have 'live' conversations with the investment community about the critical milestones Potrero Medical achieved in the past 12 months."

About Potrero Medical

Potrero Medical, Inc. is committed to addressing Acute Kidney Injury (AKI) through real-time renal assessment with the Accuryn Monitoring System, which enables early intervention of AKI to reduce preventable mortality and morbidity. The platform technology provides an automated, accurate and consistent flow of data and enables a predictive algorithm for the early detection and treatment of this disease. Potrero Medical is headquartered in Hayward, CA. For more information visit www.potreromed.com

Contact Information:
Myria Crawford
VP Marketing
[email protected]
888.635.7280

Jeff Mack
CFO
[email protected]
888.635.7280


Press Release Service by Newswire.com

Original Source: Potrero Medical to Present at 41th Annual J.P. Morgan Healthcare Conference

As of December 2022, Cedar is engaging with 22 million patients on an annualized basis, representing a 120% increase since the beginning of 2021; company is poised to continue leading the patient financial engagement market and increase its national footprint with healthcare providers and payers in 2023.

NEW YORK - January 5, 2023 - (Newswire.com)

The patient financial experience landscape has changed dramatically over the past year, as financial pressures are at an all-time high across the healthcare ecosystem. For patients, out-of-pocket spending has swelled to over $400 billion annually, while hospital operating margins continue to decline amidst a challenging labor market and ongoing supply chain issues. In order to adapt, healthcare organizations are now reevaluating how they engage with their patients and members, taking a more consumer-oriented approach. 

As a result, Cedar, an enterprise financial engagement platform that improves the end-to-end journey for consumers, continued to experience strong demand for its technology suite in 2022, improving consumer engagement and reducing administrative and billing friction across the healthcare industry. 

"We are seeing that traditional approaches to the patient financial experience are no longer driving positive outcomes for healthcare providers, payers or consumers," said Florian Otto, CEO and Co-founder of Cedar. "Over the past year, we've worked with our client partners to improve important metrics around financial results, patient satisfaction and digital engagement, leveraging our expanded Cedar Suite to simplify and optimize consumer experiences along the end-to-end healthcare journey. As we head into 2023, I'm looking forward to introducing new ways to address the systemic challenges consumers face when paying for healthcare."

Improved financial results and patient satisfaction for the nation's leading health systems

Through partnerships with more than 55 healthcare organizations, including Novant Health and Summit Health, Cedar was able to drive measurable impact across the healthcare industry: 

• As of December 2022, Cedar is engaging with 22 million patients on an annualized basis, representing a 120% increase since the beginning of 2021.
• Cedar had 13 successful go-lives with health systems and payers, including Allegheny Health Network, CentraCare and Talkiatry.
• With Cedar Pay, Cedar's flagship post-visit billing and payment solution, provider clients continued to see up to a 30% lift in patient payments and 95% digital self-service payments, with 89% of patients reporting an exceptional financial experience. 
• Cedar also demonstrated a measurable impact in improving healthcare affordability, with personalized payment plans that have both lowered default rates and increased payment rates. 
• The company's innovative technology and impact on the healthcare financial experience was recognized by FierceHealthcare, Forbes, CB Insights and Medtech Breakthrough. Additionally, Memorial Hermann Health System, a nonprofit, award-winning health system committed to creating healthier Houston communities, joined Cedar's investors in the company's Series D funding round. 

Expanded offerings to meet the needs of healthcare providers, payers and consumers 

With two new product offerings, Cedar now offers the only end-to-end patient billing platform that coordinates payer and provider outreach:

• In March 2022, Cedar launched Cedar Pre, a pre-visit product that offers a personalized, concierge experience for consumers preparing for care by facilitating financial estimates and patient intake. This solution is currently live and available, including at AnMed and Springfield Clinic.
• In November 2022, Cedar released the Payer Intelligence Layer, enabling Cedar to integrate data from health insurers and healthcare providers to create a single source of truth for consumers managing medical bills. Initially available with Cedar Pay, Cedar's billing and payment solution, the Payer Intelligence Layer enables consumers to access insurance statements, real-time deductible status and health benefit accounts in the same place where they view and resolve medical bills. Pittsburgh-based Highmark Health and Allegheny Health Network were the first to launch the new technology.

Reinforced leadership in—and advocacy for—healthcare consumerism

Cedar fostered opportunities for healthcare organizations to create consumer-grade patient experiences in a competitive marketplace:

• Cedar partnered with The Health Management Academy (The Academy) to launch The Academy-Cedar Consumer Co-Lab, bringing together senior executives from the nation's Leading Health Systems to establish an experiential learning community for healthcare leaders who emphasize fostering consumerism as a strategic priority.
• At the inaugural event, which took place in October 2022 with 48 attendees across 27 systems, Cedar introduced the Healthcare Consumer Score workshop, a first-of-its-kind measurement system for the consumer experience—specifically for healthcare.

Expanded partner ecosystem

Cedar partnered with digital health marketplaces and healthcare technology and services companies, combining expertise and product offering to bring innovation to healthcare and improve the consumer financial experience: 

• This year, Cedar became an endorsed business partner of the Hospital Association of Southern California (HASC), an endorsed partner of the Montana Hospital Association and was also awarded a purchasing agreement for Patient Engagement with Premier, Inc. 
• Following the launch of Cedar Pre, Cedar was featured as one of the first awarded suppliers on Panda Health's new solution category, Digital Patient Intake.
• Through Cedar's Payer Intelligence Layer, the company partners with HSA banks, allowing for the integration of real-time HSA, FSA and HRA balances, so consumers are informed of available funds and can make simple payments from these accounts.

Cultivated an engaging hybrid work environment

Cedar's new hybrid workstyle model is designed for the utmost flexibility, giving employees the ability to choose a workstyle that best meets their needs—whether full-time, split between home and office or periodically visiting:

• Cedar moved its headquarters to the iconic 32 Avenue of the Americas building in New York City—a space curated to promote community and connection.
• Cedar was recognized as a top place to work by Inc., Built In and Forbes, all for the second year in a row.
• Cedar fosters a collaborative and inclusive work environment, as seen in a recent Built In feature.

To learn more about Cedar, visit www.cedar.com. 

About Cedar

Cedar is committed to improving the healthcare billing experience for all. With an innovative platform that connects providers and payers, Cedar empowers healthcare consumers with an optimized journey—all powered by data science and interactive design. For Cedar clients, this leads to improved financial outcomes, more efficient operations and greater consumer loyalty. To learn more about why leading U.S. healthcare organizations trust Cedar to manage the end-to-end financial experience from pre-registration to post-visit billing, visit www.cedar.com and join us on LinkedIn, Twitter, Facebook and YouTube.

Contact Information:
Jenny Fiegoli
Cedar
[email protected]


Press Release Service by Newswire.com

Original Source: Cedar Expands Financial Engagement Platform Across Healthcare Ecosystem in 2022

Stage Analytics commits to focused growth in Health Economics and Outcomes Research (HEOR), Legal Services, Innovation and Education, and Project Management Services

ATLANTA - January 5, 2023 - (Newswire.com)

Health care consulting leader Monument Analytics announces that it has changed its name to Stage Analytics™. The new name captures the importance of Stage's work, and it reflects the firm's ongoing commitment to making a difference in the world by impacting every stage of life. 

Stage Analytics is committed to providing the highest quality scientific solutions to advance health care. They lead by incorporating integrity, innovation, and making a difference into every decision they make. Stage takes enormous pride in the work that they do and are passionate about exceeding customers' expectations. The Stage team is committed to improving the health and well-being of people all over the world.

"With this new name, our rapidly growing team is perfectly poised to fulfill our promise - continuing to deliver the highest quality of data science and health care solutions to our customers," said Dr. G. Caleb Alexander, MD, MS, Principal & Co-Founder of Stage Analytics.

The vision of Stage Analytics is to "Empower Leaders to Advance Health through Passion, Purpose and People." The company is committed to executing this vision by continuing to deliver unrivaled health care services as well as a growing portfolio of products. 

"Our focus remains unchanged, and we will continue to provide you with rigorous and customized solutions that evolve with your changing needs," Alexander said. 

Stage's new structure supports four core areas:

• Health Economics & Outcomes Research (HEOR)
• Project Management 
• Innovation & Education 
• Legal Services 

"Our mission and vision reflect the fabric of our company and, like our deliverables for clients, the remarkable commitment of every member of the team to create evidence-based solutions that advance health and health care around the globe," said Dr. William Padula, PhD, Principal & Co-Founder of Stage Analytics. 

"Our rapid growth during the past five years reflects the value of our work to clients and the remarkable demand for unassailable science that improves healthcare and health for individuals and communities alike," Padula said. "As we go forward, we are more committed than ever to continuing this heritage as Stage Analytics."

For additional information, contact Rob Rayl at [email protected] or visit us at www.stageanalytics.com. Legal Services information can be found at www.stageanalytics.legal.

About Dr. Caleb Alexander 

Dr. Alexander is a dynamic and internationally renowned physician scientist with extensive scientific, clinical, and regulatory experience in the pharmaceutical industry and public health. A practicing internist with rigorous training in many subspecialty clinical areas, Dr. Alexander is the founding director of the FDA-funded Johns Hopkins Center of Excellence in Regulatory Science and Innovation. He also has deep expertise in pharmaceutical utilization, safety, and effectiveness, with over 375 scientific publications and more than two decades of independent funding to support a large and highly productive research team. In his capacity as founding co-Director of the Johns Hopkins Center for Drug Safety and Effectiveness for the past ten years, Dr. Alexander has extensive experience working with stakeholders including payers, regulators, manufacturers, and consumer advocates. He has also served as a testifying expert in complex pharmaceutical litigation. A highly self-motivated and enterprise thinker, he is a sought-after thought leader and lecturer on a wide range of topics in drug utilization, safety, effectiveness, and policy.

About Dr. Bill Padula

Dr. Padula is an international thought leader in health economics and outcomes research with two decades of experience in academic, pharmaceutical, and medical device sectors. He is a professor of pharmaceutical & health economics at the University of Southern California, and is a Fellow in the Schaeffer Center for Health Policy & Economics in Los Angeles, CA. His work focuses on the theoretical foundations of medical cost-effectiveness analysis and its connectivity with data science. He has more than 100 scientific publications with innovative findings pertaining to surgical outcomes, vaccines, oncology, cardiovascular, neurology and immunology. He is a recognized visionary to global organizations, having served as President of the National Pressure Injury Advisory Panel, Associate Editor for Value in Health, and Commissioner for the ANCC Magnet Recognition Program. He earned a B.S. in Chemical Engineering from Northwestern University, M.S. in Health Policy from Dartmouth College, M.Sc. in Analytics from The University of Chicago, Ph.D. in Pharmacoeconomics from University of Colorado, completed his training in health economics at The University of Chicago, and was a professor at the Johns Hopkins Bloomberg School of Public Health prior to joining University of Southern California and consulting for the life sciences industry.

Contact Information:
Karen Dietz
Head of Project Management
[email protected]
6782101025

Rob Rayl
Chief Executive Officer
[email protected]
6782101025


Press Release Service by Newswire.com

Original Source: Health Care Consulting Leader Monument Analytics Will Change Its Name to Stage Analytics™

"When I joined First Stop Health eight years ago, it was because I cared deeply about expanding access to healthcare," said Gunlock. "I wanted to work towards a world where, no matter where you lived or how much money you had, high-quality healthcare would be within reach."

CHICAGO - January 4, 2023 - (Newswire.com)

First Stop Health (FSH), a leading virtual care company for primary, urgent and mental health care needs, today announced the promotion of Teira Gunlock to Chief Executive Officer. In her role, Gunlock leads a dynamic, growing organization focused on delivering convenient, high-quality and affordable care to U.S. members of its employer clients. 

"When I joined First Stop Health eight years ago, it was because I cared deeply about expanding access to healthcare," said Gunlock. "I wanted to work towards a world where, no matter where you lived or how much money you had, high-quality healthcare would be within reach. At First Stop Health, we get to bring that world a little closer to reality. I am thrilled to lead such a talented group of people who believe that healthcare should be more accessible and affordable for patients, and who dedicate themselves to making it so." 

Gunlock started at FSH in 2015, where she held the Director of Client Care role until she was promoted to Vice President in 2016. During the next few years, Gunlock continued her move up the FSH leadership team and held the roles of Senior Vice President of Operations and Chief Operating Officer. She was promoted to FSH President in April 2022, which she held before her CEO promotion. 

"I cannot tell you how satisfying and pleasing it is to have someone who has come up through the FSH ranks, as Teira has, and achieve the highest position in the company," said Patrick Spain, Co-founder and Executive Charmain at FSH. "Teira has demonstrated superb leadership abilities, which are reflected in the great results of the company this year and the overall satisfaction of all our patients, clients, doctors and partners." 

Earlier this year, FSH announced the addition of Virtual Primary Care to help improve members' health with integrated clinical services for urgent, preventive and chronic care needs. With Virtual Primary Care, in addition to its Virtual Urgent Care (Telemedicine) and Virtual Mental Health services, FSH drives high utilization with continuous, targeted employee engagement and an amazing patient experience, ensuring high-value performance and lower total healthcare costs for its employer-clients.  

Learn more about First Stop Health by visiting fshealth.com. 

About First Stop Health  

First Stop Health (FSH) provides care that people love with various digital healthcare services. Patients can access virtual care 24/7 via app, website or phone. We help them save time and money with safe, convenient, high-quality virtual care solutions - Virtual Primary Care, Virtual Urgent Care (Telemedicine) & Virtual Mental Health. FSH was named one of Inc. Magazine's Best Workplaces of 2022 and ranked one of the fastest-growing private companies for the past five years by Inc. 5000.

Contact Information:
Nick Severino
Vice President of Marketing
[email protected]
6302173067


Press Release Service by Newswire.com

Original Source: First Stop Health Promotes Teira Gunlock to CEO as Virtual Care Company Continues to Grow